Improving lifecycle management with strategic portfolio analysis

The biggest challenge confronting all companies in the biopharmaceutical industry is deciding how to invest their limited pharmaceutical market research, clinical development, and marketing dollars to maximize results while minimizing risks. A proactive portfolio analysis can help any company determine the right strategic path in a very demanding marketplace by evaluating and balancing the key success factors such as market potential, clinical development costs versus acquisition/licensing opportunities, regulatory strategies, health economics, risk management, and innovation.

For current products, market intelligence and research can create new lifecycle management strategies that preserve and extend well-established drugs, such as finding new indications, different formulations, or broader geographic markets.  The ability to extend the lifecycle of products that are already on the market can provide a substantial opportunity to increase portfolio value at a relatively low cost and with fewer risks.

A strategic analysis of products in clinical development will help biopharmaceutical companies select the strongest portfolio: one with the right balance of risk and reward; that addresses unmet medical and market needs; has the greatest chance to reach the market and achieve financial success; and aligns with company strategies.

Pharmaceutical product lifecycle strategy

PAREXEL’s extensive clinical, regulatory, and therapeutic area expertise gives us the resources to help you maximize your portfolio value at every stage of the pharmaceutical product lifecycle.  Our strategic lifecycle services include:

• In-depth market analysis
• Product positioning and labeling
• Regulatory analysis
• Trial design
• Clinical research services, Phase I through Phase IV
• Product lifecycle strategies, such as reformulation, new delivery mechanisms, and new target indications
• Risk management and mitigation
• Pharmacovigilance programs
• Market access and reimbursement strategies
• Product analysis for acquisition, licensing, and sale opportunities